The clinically significant estimated glomerular filtration rate for hyperkalemia

Internal Medicine

Volumn 47, Issue 14, 2008, Pages 1315-1323

  Takaichi, Kenmei ^a   Takemoto, Fumi ^a   Ubara, Yoshifumi ^a   Mori, Yasumichi ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

CKD; Diabetes; eGFR; Hyperkalemia; MDRD equation; RAS inhibitors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; RENIN ANGIOTENSIN SYSTEM INHIBITOR; RENIN INHIBITOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; REFERENCE VALUE; RISK FACTOR; SEX DIFFERENCE; AGE; JAPAN; KIDNEY FAILURE; MIDDLE AGED; THEORETICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERKALEMIA; JAPAN; KIDNEY FAILURE; MALE; MIDDLE AGED; MODELS, THEORETICAL; SEX FACTORS;

EID: 53049099214     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0944     Document Type: Article

References (9)

1. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13(Suppl 1): S37-S40, 2002.
2. Statistical Study Committee of Japanese Society of Dialysis Therapy: Status of chronic dialysis therapy in Japan as of December 31, 2006. Japanese Society of Dialysis Therapy, Tokyo, 2006 (in Japanese).
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 35: 1296-1305, 2004.
4. Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 68: 228-236, 2005.
5. Samak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003.
6. Japanese Society of Nephrology. Clinical practice guidelines for diagnosis and treatment of chronic kidney disease. Jpn J Nephrol 49: 755-870, 2007 (in Japanese).
7. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11: 156-163, 2007.
8. Takaichi K, Takemoto F, Ubara Y, Mori Y. Analysis of factors causing hyperkalemia. Intern Med 46: 823-829, 2007.
9. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225-232, 2003.